Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Adrenal scanning and uptake with /sup 131/1-6. beta. -iodomethyl-nor-cholesterol

Conference · · Radiology; (United States)
OSTI ID:6740786

Adrenal scans were obtained in 50 patients with suspected adrenal disease; /sup 131/I-19-iodocholesterol was used in 12 and /sup 131/I-6-..beta..-iodomethyl cholesterol (NP-59) in 38 cases (42 scans). The scan diagnosis was correct in 48 patients. Successful images were obtained with 0.5 mCi, or less, of NP-59 instead of the standard dose of 2 mCi, thus reducing radiation dose to the patient and cost of the agent. Satisfactory scans were obtained in 2 to 3 days in patients with hyperfunctioning adrenals, and in 3 to 7 days in other groups of patients, when NP-59 was used. With /sup 131/I-19-iodocholesterol, however, 5 to 10 days were required for optimal results in all patients including those with Cushing disease. Adrenal uptake studies were very useful in the evaluation of adrenal function, particularly in differentiating bilateral hyperplasia from normal adrenals.

Research Organization:
Michael Reese Hospital and Medical Center, Chicago
OSTI ID:
6740786
Journal Information:
Radiology; (United States), Journal Name: Radiology; (United States) Vol. 128:1; ISSN RADLA
Country of Publication:
United States
Language:
English